• Careers
  • News & Events
  • contact
  • Search
  • about axogen
    • about axogen
    • management team
    • board of directors
    • partners
    • international partners
    • ethics and conduct
  • our products
    • Our products
    • Avance® Nerve Graft
    • Axoguard® Nerve Connector
    • Axoguard® Nerve Protector
    • Axoguard® Nerve Cap
    • Avive® Soft Tissue Membrane
    • Axotouch® Two-Point Discriminator
  • For patients
    • patient experiences
    • About the nervous system
    • Causes of Nerve Damage
    • Nerve Damage Treatment Options
    • Peripheral Nerve Injury Map
    • Nerve Term Glossary
  • healthcare professionals
    • healthcare professionals
    • Our clinical research
    • Surgical Technique Videos
    • Understanding the mechanics of nerve repair
    • Registration and Licenses
  • investors
    • News / Events
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • Additional Information

13631 Progress Blvd, Suite 400
Alachua, FL 32615

© 2019 Axogen, Inc.

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Info
    • Contacts
    • FAQ
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • Axogen In the News
  • IR Calendar
  • Clinical Conferences
  • Presentations
  • Email Alerts

AxoGen, Inc. Announces Completion of a Pilot Clinical Study Assessing Cavernous Nerve Reconstruction with Avance® Nerve Graft Following Radical Prostatectomy

Jun 9, 2015

AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter

May 5, 2015

AxoGen, Inc. Announces Clearance from FDA to Proceed with New Multicenter Comparative Study for Avance® Nerve Graft

May 4, 2015

AxoGen, Inc. Announces 2015 Annual Shareholders’ Meeting

Apr 27, 2015

"Women's Radio Network Open Forum" To Feature AxoGen, Inc. CMO Jill Schiaparelli Discussing Women Suffering from Nerve Injuries and Options for Repair

Apr 23, 2015

AxoGen, Inc. to Report First Quarter Financial Results on May 5, 2015

Apr 21, 2015

AxoGen, Inc. to Participate in American Academy of Orthopedic Surgeons (AAOS) 2015 Annual Meeting

Mar 23, 2015

AxoGen, Inc. CEO Karen Zaderej to Discuss AxoGen's Growth, Nerve Injuries and New Options for Nerve Repair on "The Big Biz Show"

Mar 19, 2015

AxoGen, Inc. to Present at Canaccord Genuity’s Musculoskeletal Conference

Mar 16, 2015

AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter

Mar 5, 2015
RSS
    • 1...
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • ...25
    Next

    13631 Progress Blvd, Suite 400
    Alachua, FL 32615

    • contact
    • media library
    • Terms of Use
    • Privacy Policy
    • Legal Notices

    © 2021 Axogen Corporation

    Top